Browse
Register
Log In
Variables
350 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
Targeted serum metabolomics (CHRIS baseline)
x0pt029
Spermidine
Spermidine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt030
Spermine
Spermine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt031
t4-OH-Pro
trans-4-Hydroxyproline
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt033
Thr
Threonine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt034
Trp
Tryptophan
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt035
Tyr
Tyrosine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt036
Val
Valine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt037
C0
Carnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt038
C10
Decanoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt039
C10:1
Decenoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt040
C10:2
Decadienylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt041
C12
Dodecanoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt044
C14
Tetradecanoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt045
C14:1
Tetradecenoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt046
C14:1-OH
Hydroxytetradecenoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt047
C14:2
Tetradecadienylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt049
C16
Hexadecanoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt050
C16-OH
Hydroxyhexadecanoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt051
C16:1
Hexadecenoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt052
C16:1-OH
Hydroxyhexadecenoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt053
C18
Octadecanoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt054
C18:1
Octadecenoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt055
C2
Acetylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt056
C3
Propionylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt057
C3-DC (C4-OH)
Hydroxybutyrylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt058
C3:1
Propenoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt059
C4
Butyrylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt060
C4:1
Butenylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt062
C5-DC (C6-OH)
Glutarylcarnitine (Hydroxyhexanoylcarnitine)
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt063
C5-M-DC
Methylglutarylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt064
C5-OH (C3-DC-M)
Hydroxyvalerylcarnitine (Methylmalonylcarnitine)
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt065
C5:1
Tiglylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt066
C5:1-DC
Glutaconylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt067
C6 (C4:1-DC)
Hexanoylcarnitine (Fumarylcarnitine)
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt068
C6:1
Hexenoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt069
C8
Octanoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt070
C9
Nonaylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt071
H1
Hexose
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt073
lysoPC a C16:0
lysoPhosphatidylcholine acyl C16:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt074
lysoPC a C16:1
lysoPhosphatidylcholine acyl C16:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt075
lysoPC a C17:0
lysoPhosphatidylcholine acyl C17:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt076
lysoPC a C18:0
lysoPhosphatidylcholine acyl C18:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt077
lysoPC a C18:1
lysoPhosphatidylcholine acyl C18:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt078
lysoPC a C18:2
lysoPhosphatidylcholine acyl C18:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt079
lysoPC a C20:3
lysoPhosphatidylcholine acyl C20:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt081
lysoPC a C24:0
lysoPhosphatidylcholine acyl C24:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt082
lysoPC a C26:0
lysoPhosphatidylcholine acyl C26:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt083
lysoPC a C26:1
lysoPhosphatidylcholine acyl C26:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt084
lysoPC a C28:0
lysoPhosphatidylcholine acyl C28:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt085
lysoPC a C28:1
lysoPhosphatidylcholine acyl C28:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt086
PC aa C24:0
Phosphatidylcholine diacyl C24:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt087
PC aa C26:0
Phosphatidylcholine diacyl C26:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt089
PC aa C30:0
Phosphatidylcholine diacyl C30:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt090
PC aa C30:2
Phosphatidylcholine diacyl C30:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt091
PC aa C32:0
Phosphatidylcholine diacyl C32:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt092
PC aa C32:1
Phosphatidylcholine diacyl C32:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt093
PC aa C32:2
Phosphatidylcholine diacyl C32:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt094
PC aa C32:3
Phosphatidylcholine diacyl C32:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt095
PC aa C34:1
Phosphatidylcholine diacyl C34:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt096
PC aa C34:2
Phosphatidylcholine diacyl C34:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt097
PC aa C34:3
Phosphatidylcholine diacyl C34:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt098
PC aa C34:4
Phosphatidylcholine diacyl C34:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt099
PC aa C36:0
Phosphatidylcholine diacyl C36:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt101
PC aa C36:2
Phosphatidylcholine diacyl C36:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt102
PC aa C36:3
Phosphatidylcholine diacyl C36:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt103
PC aa C36:4
Phosphatidylcholine diacyl C36:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt104
PC aa C36:5
Phosphatidylcholine diacyl C36:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt105
PC aa C36:6
Phosphatidylcholine diacyl C36:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt106
PC aa C38:0
Phosphatidylcholine diacyl C38:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt107
PC aa C38:1
Phosphatidylcholine diacyl C38:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt108
PC aa C38:3
Phosphatidylcholine diacyl C38:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt109
PC aa C38:4
Phosphatidylcholine diacyl C38:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt110
PC aa C38:5
Phosphatidylcholine diacyl C38:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt111
PC aa C38:6
Phosphatidylcholine diacyl C38:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt113
PC aa C40:2
Phosphatidylcholine diacyl C40:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt114
PC aa C40:3
Phosphatidylcholine diacyl C40:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt116
PC aa C40:5
Phosphatidylcholine diacyl C40:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt117
PC aa C40:6
Phosphatidylcholine diacyl C40:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt118
PC aa C42:0
Phosphatidylcholine diacyl C42:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt119
PC aa C42:1
Phosphatidylcholine diacyl C42:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt120
PC aa C42:2
Phosphatidylcholine diacyl C42:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt121
PC aa C42:4
Phosphatidylcholine diacyl C42:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt122
PC aa C42:5
Phosphatidylcholine diacyl C42:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt123
PC aa C42:6
Phosphatidylcholine diacyl C42:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt124
PC ae C30:0
Phosphatidylcholine acyl-alkyl C30:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt126
PC ae C30:2
Phosphatidylcholine acyl-alkyl C30:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt127
PC ae C32:1
Phosphatidylcholine acyl-alkyl C32:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt128
PC ae C32:2
Phosphatidylcholine acyl-alkyl C32:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt129
PC ae C34:0
Phosphatidylcholine acyl-alkyl C34:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt130
PC ae C34:1
Phosphatidylcholine acyl-alkyl C34:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt131
PC ae C34:2
Phosphatidylcholine acyl-alkyl C34:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt132
PC ae C34:3
Phosphatidylcholine acyl-alkyl C34:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt133
PC ae C36:0
Phosphatidylcholine acyl-alkyl C36:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt134
PC ae C36:1
Phosphatidylcholine acyl-alkyl C36:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt135
PC ae C36:2
Phosphatidylcholine acyl-alkyl C36:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt136
PC ae C36:3
Phosphatidylcholine acyl-alkyl C36:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt138
PC ae C36:5
Phosphatidylcholine acyl-alkyl C36:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt139
PC ae C38:0
Phosphatidylcholine acyl-alkyl C38:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt140
PC ae C38:1
Phosphatidylcholine acyl-alkyl C38:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt141
PC ae C38:2
Phosphatidylcholine acyl-alkyl C38:2
Float
Previous
1
2
3
4
Next